These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 7293979)
21. Regression of membranoproliferative glomerulonephritis type II (dense deposit disease): observations in six children. McEnery PT; McAdams AJ Am J Kidney Dis; 1988 Aug; 12(2):138-46. PubMed ID: 3400634 [TBL] [Abstract][Full Text] [Related]
22. [Clinical and pathological analysis of fibrillary glomerulopathy]. Zhang Y; Wang S; Zou W Zhonghua Nei Ke Za Zhi; 1995 Jun; 34(6):367-70. PubMed ID: 8582180 [TBL] [Abstract][Full Text] [Related]
23. [Thin basement membrane disease in patients with asymptomatic hematuria and/or proteinuria: a clinicopathological study]. Ueno M Nihon Jinzo Gakkai Shi; 1991 Apr; 33(4):339-47. PubMed ID: 1875554 [TBL] [Abstract][Full Text] [Related]
24. [Nosological characteristics of membranes glomerulonephritis]. Serov VV; Kuprianova LA Ter Arkh; 1975; 47(4):22-6. PubMed ID: 1145476 [No Abstract] [Full Text] [Related]
27. Dense deposit disease: a subgroup of membranoproliferative glomerulonephritis, identified by electron microscopy. MacDonald MK Perspect Nephrol Hypertens; 1973; 1 Pt 1():515-30. PubMed ID: 4620925 [No Abstract] [Full Text] [Related]
28. Indentations of the glomerular basement membrane in renal diseases. A light and electron microscopic study on ultrathin serial sections. Tallqvist G; Pasternack A; Törnroth T Lab Invest; 1976 Oct; 35(4):327-36. PubMed ID: 979163 [TBL] [Abstract][Full Text] [Related]
29. Contribution of Electron Microscopy to the Clinicopathologic Diagnosis in Childhood Glomerular Renal Diseases. Arslansoyu Camlar S; Ünlü M; Soylu A; Karaca D; Sarioglu S; Kavukcu S Fetal Pediatr Pathol; 2019 Aug; 38(4):299-306. PubMed ID: 30942128 [No Abstract] [Full Text] [Related]
30. Glomerular lesions after renal transplantation. Mathew TH; Mathews DC; Hobbs JB; Kincaid-Smith P Am J Med; 1975 Aug; 59(2):177-90. PubMed ID: 1098456 [TBL] [Abstract][Full Text] [Related]
31. Rituximab for Treatment of Membranoproliferative Glomerulonephritis and C3 Glomerulopathies. Rudnicki M Biomed Res Int; 2017; 2017():2180508. PubMed ID: 28573137 [TBL] [Abstract][Full Text] [Related]
32. Long-term follow-up of type II membranoproliferative glomerulonephritis in two children. Iitaka K; Nakamura S; Moriya S; Koshino H; Iwasaki N; Motoyama O; Sakai T Clin Exp Nephrol; 2003 Mar; 7(1):58-62. PubMed ID: 14586745 [TBL] [Abstract][Full Text] [Related]
33. Immunohistological and ultrastructural differences between recurrent type I membranoproliferative glomerulonephritis and chronic transplant glomerulopathy. Andresdottir MB; Assmann KJ; Koene RA; Wetzels JF Am J Kidney Dis; 1998 Oct; 32(4):582-8. PubMed ID: 9774118 [TBL] [Abstract][Full Text] [Related]
34. Spontaneous mesangiocapillary glomerulonephritis in Finn cross lambs from Alberta. Frelier PF; Pritchard J; Armstrong DL; Nagge WT; Lewis RM Can J Comp Med; 1984 Apr; 48(2):215-8. PubMed ID: 6372972 [TBL] [Abstract][Full Text] [Related]
35. Mesangiocapillary glomerulonephritis type III and idiopathic membranous glomerulopathy. Morphometric comparison of the deposits and glomerular basement membrane including clinico-morphological correlations. Danilewicz M; Wagrowska-Danilewicz M Pol J Pathol; 1997; 48(1):43-8. PubMed ID: 9200960 [TBL] [Abstract][Full Text] [Related]